Sign in

CIK 0001842295

  • Non-accelerated filer
  • Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-850-5070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,785,701
in 13 filings, $4.6M under 10b5-1 plans

Net −$5,785,701. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-03 Courtney Phillips GC and Corp. Secretary Sale −1,990 $26.01 $52K 7,029
2026-09-03 Courtney Phillips GC and Corp. Secretary Sale −22 $25.78 $567 7,007
2026-09-02 Courtney Phillips GC and Corp. Secretary Sale −1,738 $26.38 $46K 9,262
2026-09-02 Courtney Phillips GC and Corp. Secretary Sale −243 $27.12 $7K 9,019
2026-09-01 Courtney Phillips GC and Corp. Secretary Exercise or conversion +11,000 11,000
2026-09-01 Courtney Phillips GC and Corp. Secretary Exercise or conversion · Restricted Stock Units −11,000 11,000
2026-03-02 Courtney Phillips GC and Corp. Secretary Grant or award · Stock Option (Right to Buy) +32,000 32,000
2026-03-02 Courtney Phillips GC and Corp. Secretary Grant or award · Restricted Stock Units +16,000 16,000
2025-09-22 Courtney Phillips GC and Corp. Secretary Grant or award · Restricted Stock Units +22,000 22,000

Page 1 of 1 · 9 trades